P1563CHA2DS2-VASc score predicts mortality and readmission in octogenarian patients with non-ST-segment elevation myocardial infarction

P1563CHA2DS2-VASc score predicts mortality and readmission in octogenarian patients with non-ST-segment elevation myocardial infarction

Abstract Background CHA2DS2-VASc Score is widely used to predict thromboembolic risk in patients with Atrial Fibrillation (AF). We ought to study if this score predicts outcomes in elderly patients with Non ST-segment Elevation Myocardial Infarction (NSTEMI). Methods The multicenter LONGEVO-SCA pros...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European heart journal 2019-10, Vol.40 (Supplement_1)
Hauptverfasser: Vera Sainz, A, Diez Villanueva, P, Ariza Sole, A, Formiga, F, Martinez Selles, M, Alegre, O, Sanchis, J, Marin, F, Vidan, M, Lopez Palop, R, Abu Assi, E, Bueno, H, Alfonso, F
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue Supplement_1
container_start_page
container_title European heart journal
container_volume 40
creator Vera Sainz, A
Diez Villanueva, P
Ariza Sole, A
Formiga, F
Martinez Selles, M
Alegre, O
Sanchis, J
Marin, F
Vidan, M
Lopez Palop, R
Abu Assi, E
Bueno, H
Alfonso, F
description Abstract Background CHA2DS2-VASc Score is widely used to predict thromboembolic risk in patients with Atrial Fibrillation (AF). We ought to study if this score predicts outcomes in elderly patients with Non ST-segment Elevation Myocardial Infarction (NSTEMI). Methods The multicenter LONGEVO-SCA prospective registry included 532 unselected patients with NSTEMI aged ≥80 years. Data to calculate CHA2DS2-VASc Score were available in 523 patients (98.3%). They were classified according to CHA2DS2-VASc Score: group 1 (score 0–4), and 2 (5–9). We studied outcomes in terms of mortality or readmission at 6 months follow-up. Results A total of 266 patients (51%) had a high CHA2DS2-VASc Score (group 2). They were more often women, with more cardiovascular risk factors like hypertension or diabetes mellitus, and history of previous stroke and cardiovascular disease and heart failure (all, p=0.001). Geriatric syndromes (Barthel Index, Lawton Brody, cognitive impairment and frailty) and Charlson index were worse in this group (all, p=0.001). They had poorer clinical status on admission, with worse Killip class and lower left ventricle ejection fraction (all, p=0.001), and developed new onset AF more often during admission (12.4% vs. 6.6%, p=0,024). At six months follow-up, patients in group 2 had higher reinfarction, all cause mortality, and mortality or readmission rates (all, p=0.001). (Table) A CHA2DS2-VASc Score >4 predicted mortality (HR 2,60 [95% CI 1,48–4,55], p4 is present in half of octogenarians with NSTEMI and is associated with a poor outcome.
doi_str_mv 10.1093/eurheartj/ehz748.0323
format Article
fullrecord <record><control><sourceid>oup_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_eurheartj_ehz748_0323</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/eurheartj/ehz748.0323</oup_id><sourcerecordid>10.1093/eurheartj/ehz748.0323</sourcerecordid><originalsourceid>FETCH-LOGICAL-c873-d2b46538f769b6a115cc181b4f4ae3563908c30261e321f4efae03a86244d5d93</originalsourceid><addsrcrecordid>eNqNkNtKAzEURYMoWKufIOQHUnNv5rHUS4WCQov4NqSZM23KTFKSqVJ_wN92SsVnnw7sw9qwF0K3jI4YLcQd7NMGbOq2d7D5GkszooKLMzRginNSaKnO0YCyQhGtzfslusp5Syk1mukB-n5lSovpbMLvF5y8TRYOZxcT4F2Cyrsu4zamzja-O2AbKpzAVq3P2ceAfcDRdXENwSZvA97ZzkPokU_fbXCIgSyWJMO67UMMDXz0_x5rD9HZVHnb9A21Te6YXqOL2jYZbn7vEC0fH5bTGZm_PD1PJ3PizFiQiq-kVsLUY12stGVMOccMW8laWhD9kIIaJyjXDARntYTaAhXWaC5lpapCDJE61boUc05Ql7vkW5sOJaPlUWb5J7M8ySyPMnuOnri43_0T-QGHS354</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>P1563CHA2DS2-VASc score predicts mortality and readmission in octogenarian patients with non-ST-segment elevation myocardial infarction</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><creator>Vera Sainz, A ; Diez Villanueva, P ; Ariza Sole, A ; Formiga, F ; Martinez Selles, M ; Alegre, O ; Sanchis, J ; Marin, F ; Vidan, M ; Lopez Palop, R ; Abu Assi, E ; Bueno, H ; Alfonso, F</creator><creatorcontrib>Vera Sainz, A ; Diez Villanueva, P ; Ariza Sole, A ; Formiga, F ; Martinez Selles, M ; Alegre, O ; Sanchis, J ; Marin, F ; Vidan, M ; Lopez Palop, R ; Abu Assi, E ; Bueno, H ; Alfonso, F</creatorcontrib><description>Abstract Background CHA2DS2-VASc Score is widely used to predict thromboembolic risk in patients with Atrial Fibrillation (AF). We ought to study if this score predicts outcomes in elderly patients with Non ST-segment Elevation Myocardial Infarction (NSTEMI). Methods The multicenter LONGEVO-SCA prospective registry included 532 unselected patients with NSTEMI aged ≥80 years. Data to calculate CHA2DS2-VASc Score were available in 523 patients (98.3%). They were classified according to CHA2DS2-VASc Score: group 1 (score 0–4), and 2 (5–9). We studied outcomes in terms of mortality or readmission at 6 months follow-up. Results A total of 266 patients (51%) had a high CHA2DS2-VASc Score (group 2). They were more often women, with more cardiovascular risk factors like hypertension or diabetes mellitus, and history of previous stroke and cardiovascular disease and heart failure (all, p=0.001). Geriatric syndromes (Barthel Index, Lawton Brody, cognitive impairment and frailty) and Charlson index were worse in this group (all, p=0.001). They had poorer clinical status on admission, with worse Killip class and lower left ventricle ejection fraction (all, p=0.001), and developed new onset AF more often during admission (12.4% vs. 6.6%, p=0,024). At six months follow-up, patients in group 2 had higher reinfarction, all cause mortality, and mortality or readmission rates (all, p=0.001). (Table) A CHA2DS2-VASc Score &gt;4 predicted mortality (HR 2,60 [95% CI 1,48–4,55], p&lt;0,001) (Figure 1) and was associated with mortality or readmission at 6 months (HR 2.07 [CI 95% 1.51–2.84], p&lt;0.001). CHADS VASC2 0–4 (n=257) CHADS &gt;4 (n=266) p Geriatric syndromes   Barthel Index 94 (13) 85 (22) 0.001   Lawton brody 6.2 (2) 4.9 (3) 0.001   Charlson Index 1.5 (1) 3.3 (2) 0.001 Cognitive impairment 0.001   No 201 (79.1) 155 (58.7)   Mild 49 (19.3) 100 (37.9)   Severe 4 (1.6) 9 (3.4) Nutritional risk (MNA-SF*) 122 (48) 149 (57.1) 0.040 Frailty (FRAIL scale) 0.001   Non-frail 111 (43.2) 69 (25.9)   Prefrail 102 (39.7) 101 (38)   Frail 44 (17.1) 96 (36.1) Outcomes at 6 months   Reinfarction 26 (6.9) 16 (13.9) 0.018   Mortality or readmission 111 (28.9) 60 (50.4) 0.001   All cause mortality 38 (9.9) 24 (20.2) 0.003 Conclusions A CHA2DS2-VASc sore&gt;4 is present in half of octogenarians with NSTEMI and is associated with a poor outcome.</description><identifier>ISSN: 0195-668X</identifier><identifier>EISSN: 1522-9645</identifier><identifier>DOI: 10.1093/eurheartj/ehz748.0323</identifier><language>eng</language><publisher>Oxford University Press</publisher><ispartof>European heart journal, 2019-10, Vol.40 (Supplement_1)</ispartof><rights>Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com. 2019</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,1579,27905,27906</link.rule.ids></links><search><creatorcontrib>Vera Sainz, A</creatorcontrib><creatorcontrib>Diez Villanueva, P</creatorcontrib><creatorcontrib>Ariza Sole, A</creatorcontrib><creatorcontrib>Formiga, F</creatorcontrib><creatorcontrib>Martinez Selles, M</creatorcontrib><creatorcontrib>Alegre, O</creatorcontrib><creatorcontrib>Sanchis, J</creatorcontrib><creatorcontrib>Marin, F</creatorcontrib><creatorcontrib>Vidan, M</creatorcontrib><creatorcontrib>Lopez Palop, R</creatorcontrib><creatorcontrib>Abu Assi, E</creatorcontrib><creatorcontrib>Bueno, H</creatorcontrib><creatorcontrib>Alfonso, F</creatorcontrib><title>P1563CHA2DS2-VASc score predicts mortality and readmission in octogenarian patients with non-ST-segment elevation myocardial infarction</title><title>European heart journal</title><description>Abstract Background CHA2DS2-VASc Score is widely used to predict thromboembolic risk in patients with Atrial Fibrillation (AF). We ought to study if this score predicts outcomes in elderly patients with Non ST-segment Elevation Myocardial Infarction (NSTEMI). Methods The multicenter LONGEVO-SCA prospective registry included 532 unselected patients with NSTEMI aged ≥80 years. Data to calculate CHA2DS2-VASc Score were available in 523 patients (98.3%). They were classified according to CHA2DS2-VASc Score: group 1 (score 0–4), and 2 (5–9). We studied outcomes in terms of mortality or readmission at 6 months follow-up. Results A total of 266 patients (51%) had a high CHA2DS2-VASc Score (group 2). They were more often women, with more cardiovascular risk factors like hypertension or diabetes mellitus, and history of previous stroke and cardiovascular disease and heart failure (all, p=0.001). Geriatric syndromes (Barthel Index, Lawton Brody, cognitive impairment and frailty) and Charlson index were worse in this group (all, p=0.001). They had poorer clinical status on admission, with worse Killip class and lower left ventricle ejection fraction (all, p=0.001), and developed new onset AF more often during admission (12.4% vs. 6.6%, p=0,024). At six months follow-up, patients in group 2 had higher reinfarction, all cause mortality, and mortality or readmission rates (all, p=0.001). (Table) A CHA2DS2-VASc Score &gt;4 predicted mortality (HR 2,60 [95% CI 1,48–4,55], p&lt;0,001) (Figure 1) and was associated with mortality or readmission at 6 months (HR 2.07 [CI 95% 1.51–2.84], p&lt;0.001). CHADS VASC2 0–4 (n=257) CHADS &gt;4 (n=266) p Geriatric syndromes   Barthel Index 94 (13) 85 (22) 0.001   Lawton brody 6.2 (2) 4.9 (3) 0.001   Charlson Index 1.5 (1) 3.3 (2) 0.001 Cognitive impairment 0.001   No 201 (79.1) 155 (58.7)   Mild 49 (19.3) 100 (37.9)   Severe 4 (1.6) 9 (3.4) Nutritional risk (MNA-SF*) 122 (48) 149 (57.1) 0.040 Frailty (FRAIL scale) 0.001   Non-frail 111 (43.2) 69 (25.9)   Prefrail 102 (39.7) 101 (38)   Frail 44 (17.1) 96 (36.1) Outcomes at 6 months   Reinfarction 26 (6.9) 16 (13.9) 0.018   Mortality or readmission 111 (28.9) 60 (50.4) 0.001   All cause mortality 38 (9.9) 24 (20.2) 0.003 Conclusions A CHA2DS2-VASc sore&gt;4 is present in half of octogenarians with NSTEMI and is associated with a poor outcome.</description><issn>0195-668X</issn><issn>1522-9645</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNqNkNtKAzEURYMoWKufIOQHUnNv5rHUS4WCQov4NqSZM23KTFKSqVJ_wN92SsVnnw7sw9qwF0K3jI4YLcQd7NMGbOq2d7D5GkszooKLMzRginNSaKnO0YCyQhGtzfslusp5Syk1mukB-n5lSovpbMLvF5y8TRYOZxcT4F2Cyrsu4zamzja-O2AbKpzAVq3P2ceAfcDRdXENwSZvA97ZzkPokU_fbXCIgSyWJMO67UMMDXz0_x5rD9HZVHnb9A21Te6YXqOL2jYZbn7vEC0fH5bTGZm_PD1PJ3PizFiQiq-kVsLUY12stGVMOccMW8laWhD9kIIaJyjXDARntYTaAhXWaC5lpapCDJE61boUc05Ql7vkW5sOJaPlUWb5J7M8ySyPMnuOnri43_0T-QGHS354</recordid><startdate>20191001</startdate><enddate>20191001</enddate><creator>Vera Sainz, A</creator><creator>Diez Villanueva, P</creator><creator>Ariza Sole, A</creator><creator>Formiga, F</creator><creator>Martinez Selles, M</creator><creator>Alegre, O</creator><creator>Sanchis, J</creator><creator>Marin, F</creator><creator>Vidan, M</creator><creator>Lopez Palop, R</creator><creator>Abu Assi, E</creator><creator>Bueno, H</creator><creator>Alfonso, F</creator><general>Oxford University Press</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20191001</creationdate><title>P1563CHA2DS2-VASc score predicts mortality and readmission in octogenarian patients with non-ST-segment elevation myocardial infarction</title><author>Vera Sainz, A ; Diez Villanueva, P ; Ariza Sole, A ; Formiga, F ; Martinez Selles, M ; Alegre, O ; Sanchis, J ; Marin, F ; Vidan, M ; Lopez Palop, R ; Abu Assi, E ; Bueno, H ; Alfonso, F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c873-d2b46538f769b6a115cc181b4f4ae3563908c30261e321f4efae03a86244d5d93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vera Sainz, A</creatorcontrib><creatorcontrib>Diez Villanueva, P</creatorcontrib><creatorcontrib>Ariza Sole, A</creatorcontrib><creatorcontrib>Formiga, F</creatorcontrib><creatorcontrib>Martinez Selles, M</creatorcontrib><creatorcontrib>Alegre, O</creatorcontrib><creatorcontrib>Sanchis, J</creatorcontrib><creatorcontrib>Marin, F</creatorcontrib><creatorcontrib>Vidan, M</creatorcontrib><creatorcontrib>Lopez Palop, R</creatorcontrib><creatorcontrib>Abu Assi, E</creatorcontrib><creatorcontrib>Bueno, H</creatorcontrib><creatorcontrib>Alfonso, F</creatorcontrib><collection>CrossRef</collection><jtitle>European heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vera Sainz, A</au><au>Diez Villanueva, P</au><au>Ariza Sole, A</au><au>Formiga, F</au><au>Martinez Selles, M</au><au>Alegre, O</au><au>Sanchis, J</au><au>Marin, F</au><au>Vidan, M</au><au>Lopez Palop, R</au><au>Abu Assi, E</au><au>Bueno, H</au><au>Alfonso, F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>P1563CHA2DS2-VASc score predicts mortality and readmission in octogenarian patients with non-ST-segment elevation myocardial infarction</atitle><jtitle>European heart journal</jtitle><date>2019-10-01</date><risdate>2019</risdate><volume>40</volume><issue>Supplement_1</issue><issn>0195-668X</issn><eissn>1522-9645</eissn><abstract>Abstract Background CHA2DS2-VASc Score is widely used to predict thromboembolic risk in patients with Atrial Fibrillation (AF). We ought to study if this score predicts outcomes in elderly patients with Non ST-segment Elevation Myocardial Infarction (NSTEMI). Methods The multicenter LONGEVO-SCA prospective registry included 532 unselected patients with NSTEMI aged ≥80 years. Data to calculate CHA2DS2-VASc Score were available in 523 patients (98.3%). They were classified according to CHA2DS2-VASc Score: group 1 (score 0–4), and 2 (5–9). We studied outcomes in terms of mortality or readmission at 6 months follow-up. Results A total of 266 patients (51%) had a high CHA2DS2-VASc Score (group 2). They were more often women, with more cardiovascular risk factors like hypertension or diabetes mellitus, and history of previous stroke and cardiovascular disease and heart failure (all, p=0.001). Geriatric syndromes (Barthel Index, Lawton Brody, cognitive impairment and frailty) and Charlson index were worse in this group (all, p=0.001). They had poorer clinical status on admission, with worse Killip class and lower left ventricle ejection fraction (all, p=0.001), and developed new onset AF more often during admission (12.4% vs. 6.6%, p=0,024). At six months follow-up, patients in group 2 had higher reinfarction, all cause mortality, and mortality or readmission rates (all, p=0.001). (Table) A CHA2DS2-VASc Score &gt;4 predicted mortality (HR 2,60 [95% CI 1,48–4,55], p&lt;0,001) (Figure 1) and was associated with mortality or readmission at 6 months (HR 2.07 [CI 95% 1.51–2.84], p&lt;0.001). CHADS VASC2 0–4 (n=257) CHADS &gt;4 (n=266) p Geriatric syndromes   Barthel Index 94 (13) 85 (22) 0.001   Lawton brody 6.2 (2) 4.9 (3) 0.001   Charlson Index 1.5 (1) 3.3 (2) 0.001 Cognitive impairment 0.001   No 201 (79.1) 155 (58.7)   Mild 49 (19.3) 100 (37.9)   Severe 4 (1.6) 9 (3.4) Nutritional risk (MNA-SF*) 122 (48) 149 (57.1) 0.040 Frailty (FRAIL scale) 0.001   Non-frail 111 (43.2) 69 (25.9)   Prefrail 102 (39.7) 101 (38)   Frail 44 (17.1) 96 (36.1) Outcomes at 6 months   Reinfarction 26 (6.9) 16 (13.9) 0.018   Mortality or readmission 111 (28.9) 60 (50.4) 0.001   All cause mortality 38 (9.9) 24 (20.2) 0.003 Conclusions A CHA2DS2-VASc sore&gt;4 is present in half of octogenarians with NSTEMI and is associated with a poor outcome.</abstract><pub>Oxford University Press</pub><doi>10.1093/eurheartj/ehz748.0323</doi></addata></record>
fulltext fulltext
identifier ISSN: 0195-668X
ispartof European heart journal, 2019-10, Vol.40 (Supplement_1)
issn 0195-668X
1522-9645
language eng
recordid cdi_crossref_primary_10_1093_eurheartj_ehz748_0323
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection
title P1563CHA2DS2-VASc score predicts mortality and readmission in octogenarian patients with non-ST-segment elevation myocardial infarction
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T02%3A20%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=P1563CHA2DS2-VASc%20score%20predicts%20mortality%20and%20readmission%20in%20octogenarian%20patients%20with%20non-ST-segment%20elevation%20myocardial%20infarction&rft.jtitle=European%20heart%20journal&rft.au=Vera%20Sainz,%20A&rft.date=2019-10-01&rft.volume=40&rft.issue=Supplement_1&rft.issn=0195-668X&rft.eissn=1522-9645&rft_id=info:doi/10.1093/eurheartj/ehz748.0323&rft_dat=%3Coup_cross%3E10.1093/eurheartj/ehz748.0323%3C/oup_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_oup_id=10.1093/eurheartj/ehz748.0323&rfr_iscdi=true